Covid-19: AIIMS to start human clinical trial of Covaxin from Monday

Covaxin is being tested in 12 places, according to the Indian Council for Medical Research.

The All India Institute of Medical Sciences (AIIMS) will from Monday conduct human clinical trials of the indigenously developed Covid-19 vaccine candidate Covaxin, said a senior doctor of the Delhi hospital.

Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS told news ageny ANI, an ethics committee had approved the trials.

"Today, we got approval from AIIMS Ethics Committee for starting the human clinical trial of the indigenously developed Covaxin. We are launching the enrollment process from Monday. We are going to select healthy participants with no comorbidities and without a history of Covid-19. The age group of the